FUNKCIJOM BUBREGA in English translation

• renal function
• kidney function
• renal impairment

Examples of using Funkcijom bubrega in Croatian and their translations into English

Cayston bolesnicima s oštećenom funkcijom bubrega(kreatinin u serumu>
therefore administration of Cayston in patients with renal impairment(serum creatinine>

Boja joda koja se koristi tijekom ovog testa može uzrokovati oštećenje bubrega kod ljudi sa slabom funkcijom bubrega.
The iodine dye which is used during this test has a potential to cause kidney damage to people with poor kidney function.

U ispitivanjuAPEX procjenjivana je djelotvornost kod 40 bolesnika s oštećenom funkcijom bubrega tj. početna razina kreatinina u serumu> 1, 5 mg/dl i ≤2, 0 mg/dl.
The APEX Study evaluated efficacy in 40 patients with renal impairment i.e., baseline serum creatinine> 1.5 mg/dL and2.0 mg/dL.

Ako imate problema sa sluhom ili funkcijom bubrega, Vaš liječnik može uzeti uzorak krvi kako bi provjerio razinu lijeka Vantobra u Vašem organizmu.
If you have problems with your hearing or kidney function, your doctor may take blood samples to monitor the amount of Vantobra in your system.

Liječenje lijekom MIRCERA mora započeti pod nadzorom liječnika s iskustvom u liječenju bolesnika s narušenom funkcijom bubrega.
Treatment with MIRCERA has to be initiated under the supervision of a physician experienced in the management of patients with renal impairment.

Jinarc se koristi u bolesnika s normalnom do umjereno smanjenom funkcijom bubrega na početku terapije lijekom Jinarc
Jinarc is for use in patients with normal to moderately reduced kidney function at the beginning of treatment with Jinarc

Nema dostupnih podataka o primjeni TMZ-a u bolesnika s teškim oštećenjem funkcije jetre(stadij C po Childu) ili s oštećenom funkcijom bubrega.
No data are available on the administration of TMZ in patients with severe hepatic impairment(Child's Class C) or with renal impairment.

To treba uzeti u obzir kod pacijenata s oslabljenom funkcijom bubrega ili kod pacijenata na prehrani s kontroliranim unosom kalija.
This must be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.

se ne očekuje smanjenje ukupnog tjelesnog klirensa u bolesnika s oslabljenom funkcijom bubrega.
a decrease in the total body clearance is not expected in patients with renal impairment.

Nadalje, lijek Cresemba ima prednost da se može primijeniti u bolesnika sa smanjenom funkcijom bubrega.
In addition, Cresemba has the advantage that it can be used in patients with reduced kidney function.

postoje ozbiljni problemi s funkcijom bubrega.
unless there are serious problems with kidney function.

Stoga se ne preporuča primjena lijeka Invokana u bolesnika s ozbiljno smanjenom funkcijom bubrega.
The use of Invokana is therefore not recommended in patients with severely reduced kidney function.

O tome treba voditi računa u bolesnika sa smanjenom funkcijom bubrega ili bolesnika s ograničenjem unosa kalija.
To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.

Ovaj podatak potrebno je uzeti u obzir u bolesnika s oštećenom funkcijom bubrega ili u bolesnika na prehrani s kontroliranim unosom kalija.
To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.

Ovo treba uzeti u obzir u bolesnika sa smanjenom funkcijom bubrega ili bolesnika s ograničenjem unosa kalija.
To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.

U bolesnika s oštećenom funkcijom bubrega potrebno je prije početka liječenja procijeniti moguće rizike i koristi od terapije anagrelidom vidjeti dio 4.3.
The potential risks and benefits of anagrelide therapy in a patient with impairment of renal function should be assessed before treatment is commenced see section 4.3.

Unutarstanični i plazma farmakokinetika tenofovir disoproksil fumarata(TDF) 300mg svaki 48 sati odnosu 150mg/ dan u odrasle osobe inficirane HIV-om s umjereno oslabljenom funkcijom bubrega, Klinička zarazna dis, uređivanje na mreži.
Intracellular plasma and the pharmacokinetics of tenofovir disoproxil fumarate(TDF) 300mg at each 48 hours versus 150mg/ day in HIV-infected adults with moderate impairment of renal function.

izloženost tenofoviru povećava se u pacijenata s poremećenom funkcijom bubrega.
the exposure to tenofovir increases in patients with renal dysfunction.

Competact se ne smije primjenjivati u bolesnika s bubrežnim zatajenjem ili poremećenom funkcijom bubrega(klirens kreatinina<
Competact should not be used in patients with renal failure or renal dysfunction(creatinine clearance<

U nekih bolesnika s kompromitiranom funkcijom bubrega(dehidrirani bolesnici
In some patients with compromised renal function(dehydrated patients